3-methylhistidine has been researched along with Lung Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Block, JB; Chlebowski, RT; Heber, D; Herrold, JN; Ishibashi, DE | 1 |
| Cardillo, T; Davis, CS; Dreicer, R; Forest, PK; Kemp, JD; See, WA; Stegink, LD | 1 |
1 trial(s) available for 3-methylhistidine and Lung Neoplasms
| Article | Year |
|---|---|
A phase II trial of deferoxamine in patients with hormone-refractory metastatic prostate cancer.
Topics: Adenocarcinoma; Aged; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Creatinine; Deferoxamine; Drug Resistance, Neoplasm; Humans; Hydroxyproline; Infusions, Intravenous; Lung Neoplasms; Lymphatic Metastasis; Male; Methylhistidines; Middle Aged; Pelvis; Prostatic Neoplasms | 1997 |
1 other study(ies) available for 3-methylhistidine and Lung Neoplasms
| Article | Year |
|---|---|
Abnormalities in glucose and protein metabolism in noncachectic lung cancer patients.
Topics: Aged; Body Weight; Carcinoma, Bronchogenic; Cyclophosphamide; Doxorubicin; Drug Therapy, Combination; Glucose; Humans; Lomustine; Lung Neoplasms; Methylhistidines; Middle Aged; Muscles; Nutritional Physiological Phenomena; Proteins; Reference Values; Vincristine | 1982 |